EKSO

100.00% -11.80

Dopo l'orario di chiusura: 12.00 12.00 +

Ekso Bionics Holdings Inc (EKSO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché EKSO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Ekso Bionics Holdings Inc Stock (EKSO) Company Profile

Ekso Bionics Holdings Inc

Healthcare (1108)

510-984-1761

101 GLACIER POINT, SAN RAFAEL

@EksoBionics

Prossima data di guadagno

Ultimi documenti SEC

EKSO's Discussions on Twitter

Compare EKSO vs ISRG, BDX, ALC, MDLN, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EKSO Ekso Bionics Holdings Inc	0.00	42.05M	11.57M	-16.07M	-12.14M	-5.3918
ISRG Intuitive Surgical Inc	402.95	144.07B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	140.71	39.67B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	65.18	31.54B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	34.71	30.39B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	188.45	27.36B	5.54B	1.52B	1.74B	10.37

Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2016-10-14	Iniziato	SunTrust	Buy

Ekso Bionics Holdings Inc Borsa (EKSO) Ultime notizie

Ekso Bionics Holdings Inc Azioni (EKSO) Dati Finanziari

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc Stock (EKSO) Company Profile

Compare EKSO vs ISRG, BDX, ALC, MDLN, RMD

Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades

Ekso Bionics Holdings Inc Borsa (EKSO) Ultime notizie

Ekso Bionics Holdings Inc (EKSO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Ekso Bionics Holdings Inc (EKSO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Ekso Bionics Holdings Inc (EKSO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Ekso Bionics Holdings Inc (EKSO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Ekso Bionics (EKSO) Holds Gains as Stock Tests Near-Term Resistance LevelsIchimoku Cloud - newsline.com

Ekso Bionics Holdings Stock (US2826641040): Ticker Change To ChronoScale Raises Questions For Legacy - AD HOC NEWS

Ekso Bionics (EKSO) Shows Modest Gains as Shares Approach Resistance LevelStock Buy Zone - newsline.com

Chronoscale To Divest Ekso Bionics And Focus On Cloud Business - TradingView

ChronoScale (NASDAQ: CHRN) plans Ekso divestiture to become cloud-focused - Stock Titan

Industrial Exoskeletons Market Is Going to Boom |• Ekso Bionics • SuitX • Sarcos Robotics - openPR.com

ChronoScale Corporation: Shareholders Board Members Managers and Company Profile | US1709241046 - marketscreener.com

Ekso Bionics (EKSO) Climbs 1.29% as Stock Tests Key Resistance LevelTechnical Analysis Picks - The Legal Advocate

Ekso Bionics (EKSO) Gains Ground as Shares Approach Key ResistanceFactor Timing - The Legal Advocate

CHRN - Finviz

Ekso Bionics (EKSO) Moves Higher as Stock Tests Resistance Near $12.39Zero Lag EMA - The Legal Advocate

ChronoScale Corporation (formerly Ekso Bionics) Files 8-K/A Amendment Detailing Phantom PSU Awards for Executives - Minichart

ChronoScale (CHRN) shifts executive phantom PSU payouts to stock and cash - Stock Titan

ChronoScale Corp (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan

ChronoScale (CHRN) director Wes Cummins granted 200,000 restricted shares in equity award - Stock Titan

[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity - Stock Titan

Richard Nottenburg awarded 200K ChronoScale (CHRN) restricted shares - Stock Titan

ChronoScale (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan

ChronoScale (CHRN) director receives 109,357-share equity grant in Form 4 filing - Stock Titan

Sports Exoskeleton Market to Reach USD 1,543.98 Million by 2033 - openPR.com

Ekso Bionics Holdings stock (US2826641040): Q1 2026 results and exoskeleton strategy in focus - AD HOC NEWS

ChronoScale (CHRN) director Richard Nottenburg files Form 3 with no trades - Stock Titan

ChronoScale Corp (CHRN) director reports 3.56M shares tied to incentive plan units - Stock Titan

Armistice Capital (CHRN) reports 187,151 shares, 4.99% ownership - Stock Titan

ChronoScale (CHRN) CEO and director file initial insider ownership - Stock Titan

CHRN SEC FilingsChronoScale Corp 10-K, 10-Q, 8-K Forms - Stock Titan

EKSO SEC FilingsEkso Bionics 10-K, 10-Q, 8-K Forms - Stock Titan

Ekso Bionics Holdings stock (US2826641040): Pioneering exoskeleton tech for medical and industrial u - AD HOC NEWS

Mink Brook amendment shows 0 CHRN shares held by related entities (CHRN) - Stock Titan

Walk Assist Robot Market Research Report 2026-2031: Leading firms Such as Ekso Bionics, Lifeward, Cyberdyne, Ottobock, and DIH Medical Lead the $568.81 Million Market - Yahoo Finance

TradingKey - TradingKey

Applied Digital gains control of ChronoScale (NASDAQ: EKSO) with 97.5% stake - Stock Titan

Exoskeleton News, May 2026 – Week 19 – Numerous new events and much more… - Exoskeleton Report

Applied Digital Just Spun Out ChronoScale: What CHRN Means for APLD Stock Now - TechStock²

ChronoScale names Cenly Chen CEO to drive AI compute expansion - MSN

CHRN Should I Buy - Intellectia AI

Ekso Bionics Holdings: Fundamental Analysis and Financial Ratings | EKSO | US2826444000 - marketscreener.com

ChronoScale Corporation Common Stock (CHRN) 10K Form and Latest SEC Filings 2026 - MarketBeat

ChronoScale Corporation Common Stock (CHRN) Insider Trading Activity 2026 - MarketBeat

ChronoScale Corporation Common Stock (CHRN) Stock Price, News & Analysis - MarketBeat

CHRN PE Ratio & Valuation, Is CHRN Overvalued - Intellectia AI

ChronoScale Names Cenly Chen CEO to Lead Expansion of AI Compute Infrastructure - citybiz

CHRN Technical Analysis & Stock Price Forecast - Intellectia AI

ChronoScale names Cenly Chen as chief executive officer By Investing.com - Investing.com South Africa

ChronoScale names Cenly Chen as chief executive officer - Investing.com

ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth - The Manila Times

Ekso Bionics Holdings: Shareholders Board Members Managers and Company Profile | US2826444000 - marketscreener.com

Ekso Bionics Holdings Inc Azioni (EKSO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a EKSO